Close

Ayala Pharmaceuticals Inc. (AYLA) Reports Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102

Go back to Ayala Pharmaceuticals Inc. (AYLA) Reports Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102
(NASDAQ: AYLA) Delayed: 0.50 --0 (-0%)
Previous Close $0.50    52 Week High
Open $0.50    52 Week Low
Day High $0.50    P/E N/A 
Day Low $0.50    EPS
Volume 153,805